ASO Author Reflections: Hepatic Resection as the Primary Treatment Modality for Hepatocellular Carcinoma After Orthotopic Liver Transplantation
Ann Surg Oncol
.
2024 Sep 14.
doi: 10.1245/s10434-024-16237-1.
Online ahead of print.
Authors
Abraham J Matar
1
,
Kailey M Oppat
2
,
Frances J Bennett
2
,
Emilie A K Warren
2
,
Chase J Wehrle
3
,
Zhihao Li
4
,
Luckshi Rajendran
4
,
Zachary P Rokop
5
,
Chandrashekhar Kubal
5
,
Ben E Biesterveld
6
,
David P Foley
6
,
Mayumi Maeda
7
,
Mindie H Nguyen
7
,
Beth Elinoff
8
,
Abhinav Humar
8
,
Dimitrios Moris
9
,
Debra Sudan
9
,
John Klein
10
,
Juliet Emamaullee
10
,
Vatche Agopian
11
,
Parsia A Vagefi
12
,
Shukri H A Dualeh
13
,
Christopher J Sonnenday
13
,
Gonzalo Sapisochin
4
,
Federico N Aucejo
3
,
Shishir K Maithel
2
Affiliations
1
Emory University, Atlanta, GA, USA. matar033@umn.edu.
2
Emory University, Atlanta, GA, USA.
3
Cleveland Clinic, Cleveland, OH, USA.
4
Ajmera Transplant Center and HPB Surgical Oncology, University Health Network, Toronto, ON, Canada.
5
Indiana University Health, Indianapolis, IN, USA.
6
School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
7
Stanford University Medical Center, Palo Alto, CA, USA.
8
University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
9
Duke University School of Medicine, Durham, NC, USA.
10
University of Southern California, Los Angeles, CA, USA.
11
David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
12
UT Southwestern Medical Center, Dallas, TX, USA.
13
University of Michigan, Ann Arbor, MI, USA.
PMID:
39277547
DOI:
10.1245/s10434-024-16237-1
No abstract available